Oramorph and dyspnoea Patient Reports February 13, 2012
Oramorph Side Effects Report #5348121-3
Oramorph side effect was reported by a Physician from on June 05, 2007. Female patient, 59 years of age, was diagnosed with pain
, cholecystitis, hypertension, haemoglobin decreased, thyroid disorder and was treated with Oramorph. After drug was administered, patient experienced the following side effects: dyspnoea, hepatitis
, rash pruritic, swollen tongue. Oramorph dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, GENTAMICIN, LOSARTAN POTASSIUM, FERROUS SULPHATE, LEVOTHYROXINE. Patient recovered.Oramorph Side Effects Report #5400944-8
Oramorph side effect was reported by a Physician from on July 27, 2007. Female patient, 59 years of age, was diagnosed with pain
, cholecystitis, hypertension, haemoglobin decreased, thyroid disorder and was treated with Oramorph. After drug was administered, patient experienced the following side effects: dyspnoea, swollen tongue. Oramorph dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, GENTAMICIN, LOSARTAN POTASSIUM, FERROUS SULPHATE, LEVOTHYROXINE. Patient recovered.Oramorph Side Effects Report #5730200-X
Oramorph side effect was reported by a Health Professional from UNITED KINGDOM on Apr 18, 2008. Female patient, 43 years of age, was diagnosed with pain
, breast cancer metastatic and was treated with Oramorph. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, c-reactive protein increased, dehydration, dyspnoea, hyponatraemia, hypotension, nausea
, oral intake reduced. Oramorph dosage: unknown. During the same period patient was treated with LAPATINIB, CAPECITABINE. Patient was hospitalized. Patient died on 04/02/2008.Oramorph Side Effects Report #5642566-X
Oramorph side effect was reported by a Physician from UNITED STATES on Feb 27, 2008. Female patient, 60 years of age, was diagnosed with myofascial pain syndrome and was treated with Oramorph. After drug was administered, patient experienced the following side effects: dyspnoea, hallucination, palpitations, stomach discomfort. Oramorph dosage: SR 100MG ONE QD #30 (ORAL). During the same period patient was treated with METHADONE. Patient recovered.
Oramorph and dyspnoea 